Recent publications on Cancer

Lee JK, Roy A, Jensen CD, Chan JT, Zhao WK, Levin TR, Chubak J, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman AN, Kamineni A, Udaltsova N, Corley DA. Surveillance colonoscopy findings in older adults with a history of colorectal adenomas.  JAMA Netw Open. 2024;7(4):e244611. doi: 10.1001/jamanetworkopen.2024.4611.  PubMed

Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer.  JCO Clin Cancer Inform. 2024;8:e2300209. doi: 10.1200/CCI.23.00209.  PubMed

Mullooly M, Fan S, Pfeiffer RM, Bowles EA, Duggan MA, Falk RT, Richert-Boe K, Glass AG, Kimes TM, Figueroa JD, Rohan TE, Abubakar M, Gierach GL. Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease.  Breast Cancer Res. 2024;26(1):52. doi: 10.1186/s13058-024-01764-2.  PubMed

Fairman CM, Kava CM, Beima-Sofie K, Sakhuja M, Masud M, Dias E, Sheng J, Gorzelitz J, Morshed A, Green BB, Skiba MB, Madhivanan P, Parthasarathy N, Hirschey R, Vander Weg MW, Hebert J. Addressing differences in cancer: A framework for synergistic programming in cancer prevention and control. Res Sq [Preprint]. 2024:rs.3.rs-4046415. doi: 10.21203/rs.3.rs-4046415/v1.  PubMed

Hubbard RA, Su YR, Bowles EJ, Ichikawa L, Kerlikowske K, Lowry KP, Miglioretti DL, Tosteson ANA, Wernli KJ, Lee JM. Predicting five-year interval second breast cancer risk in women with prior breast cancer. J Natl Cancer Inst. 2024 Mar 11:djae063. doi: 10.1093/jnci/djae063 [Epub ahead of print] PubMed

Luce C, Palazzo L, Anderson ML, Carter-Bawa L, Gao H, Green BB, Ralston JD, Rogers K, Su YR, Tuzzio L, Triplette M, Wernli KJ. A pragmatic randomized clinical trial of multilevel interventions to improve adherence to lung cancer screening (The Larch Study): Study protocol.  Contemp Clin Trials. 2024 Mar 11;140:107495. doi: 10.1016/j.cct.2024.107495 [Epub ahead of print] PubMed

Head M, Cohn B, Wernli KJ, Palazzo L, Ehrlich K, Matson A, Knerr S. Young women's perspectives on being screened for hereditary breast and ovarian cancer risk during routine primary care. Womens Health Issues. 2024 Mar 5:S1049-3867(24)00004-5. doi: 10.1016/j.whi.2024.01.004. PubMed

Kessler LG, Comstock B, Aiello Bowles EJ, Mou J, Nash MG, Bravo P, Fleckenstein LE, Pflugeisen C, Gao H, Winer RL, Ornelas IJ, Smith C, Neslund-Dudas C, Shetty P. Protocol to measure validity and reliability of colorectal, breast, cervical and lung cancer screening questions from the 2021 National Health Interview Survey: Methodology and design. PLoS One.. 2024 Mar 4;19(3):e0297773. doi: 10.1371/journal.pone.0297773. eCollection 2024. PubMed

Lee JK, Jensen CD, Udaltsova N, Zheng Y, Levin TR, Chubak J, Kamineni A, Halm EA, Skinner CS, Schottinger JE, Ghai NR, Burnett-Hartman A, Issaka R, Corley DA. Predicting risk of colorectal cancer after adenoma removal in a large, community-based setting. Am J Gastroenterol. 2024 Feb 14. doi: 10.14309/ajg.0000000000002721. [Epub ahead of print]. PubMed

Abrahão R, Brunson A, Ruddy KJ, Li Q, Li J, Ryder MM, Chubak J, Nichols HB, Sauder CAM, Gray MF, Hahn EE, Wun T, Keegan THM. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study. Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02594-x. [Epub ahead of print]. PubMed

Hai J, Meyer SN, Wong SL, Li Y, Simmons E, Miglioretti D, Fung M, Kiuru M. Comparison of S100A8 and PRAME as biomarkers for distinguishing melanoma from melanocytic nevus: a case-control analysis. Clin Exp Dermatol. 2024 Feb 2:llae005. doi: 10.1093/ced/llae005. PubMed

Figueroa Gray M, Randall S, Banegas M, Ryan GW, Henrikson NB. Personal legacy and treatment choices for serious illness: A scoping review. BMJ Support Palliat Care. 2024 Jan 24:spcare-2023-004439. doi: 10.1136/spcare-2023-004439. [Epub ahead of print]. PubMed

Abrahão R, Brunson A, Chubak J, Wernli KJ, Nichols HB, Chao C, Ruddy KJ, Hahn EE, Li Q, Malogolowkin MH, Sauder CAM, Kushi LH, Wun T, Keegan THM. Late venous thromboembolism in survivors of adolescent and young adult cancer: A population-based study in California.  Thromb Res. 2024;235:1-7. doi: 10.1016/j.thromres.2024.01.002. Epub 2024 Jan 15.  PubMed

White LL, Burnett-Hartman AN, Ichikawa LE, Goldberg SR, Chubak J, Spencer Feigelson H, Kamineni A. SARS-CoV-2 infection and related hospitalization among cancer survivors. Cancer Epidemiol Biomarkers Prev. 2023 Dec 21. doi: 10.1158/1055-9965.EPI-23-1303. [Epub ahead of print]. PubMed

Aiello Bowles EJ, Kroenke CH, Chubak J, Bhimani J, O'Connell K, Brandzel S, Valice E, Doud R, Theis MK, Roh JM, Heon N, Persaud S, Griggs JJ, Bandera EV, Kushi LH, Kantor ED. Evaluation of algorithms using automated health plan data to identify breast cancer recurrences. Cancer Epidemiol Biomarkers Prev. 2023 Dec 13. doi: 10.1158/1055-9965.EPI-23-0782. [Epub ahead of print]. PubMed

Kerlikowske K, Chen S, Bissell MCS, Lee CI, Tice JA, Sprague BL, Miglioretti DL. Population attributable risk of advanced-stage breast cancer by race and ethnicity. JAMA Oncol. 2023 Dec 7:e235242. doi: 10.1001/jamaoncol.2023.5242. [Epub ahead of print]. PubMed

Winer RL, Lin J, Anderson ML, Tiro JA, Green BB, Gao H, Meenan RT, Hansen K, Sparks A, Buist DSM. Strategies to increase cervical cancer screening with mailed human papillomavirus self-sampling kits: A randomized clinical trial. JAMA. 2023 Nov 28;330(20):1971-1981. doi: 10.1001/jama.2023.21471. PubMed

Atakpa EC, Buist DSM, Bowles EJA, Cuzick J, Brentnall AR. Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: A cohort study. Breast Cancer Res. 2023 Nov 24. doi:10.1186/s13058-023-01744-y. Online ahead of print. PubMed

Gard CC, Tice JA, Miglioretti DL, Sprague BL, Bissell MCS, Henderson LM, Kerlikowske K. Extending the Breast Cancer Surveillance Consortium model of invasive breast cancer. J Clin Oncol. 2023 Nov 17:JCO2202470. doi: 10.1200/JCO.22.02470 [Epub ahead of print] PubMed

Liu PH, Nair RG, Skinner CS, Murphy CC, Kim EJ, Ortiz C, Wang L, Hu E, Lykken JM, Levin TR, Green BB, Hahn EE, Santini N, Halm EA. Unsatisfactory fecal immunochemical tests for colorectal cancer screening: prevalence, reasons, and subsequent testing. Cancer Epidemiol Biomarkers Prev. 2023 Nov 15:OF1-OF9. doi: 10.1158/1055-9965.EPI-23-0507. Online ahead of print. PubMed